SOHM, INC. FINANCIAL REPORT FOR THE QUARTER ENDED September 30, 2021
**At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution.
**SHMN’s proprietary processes and formulation capability allow it to develop generic formulations of brand name drugs that don’t infringe on valid patents relating to the brand-name product.
**The Company is headquartered in Chino Hills, California, U.S.A. and the Company’s strategic manufacturing facility is located in Southern California, in an area considered one of the safest and perfect for pharmaceutical operations. The facility is approximately 5,500 square feet.
**The company implemented new distribution of product policy, where in super distributor have been replaced by CSA & CFA for effective and regulated sales.
**One of the major hurdles that is faced today is when large scale chain of store evaluates the products and innovation, it demands scale of response.